- Ion Torrent To Be Acquired by Life Technologies - August 17, 2010
- EnteroMedics Achieves Major Milestones for the Maestro System - August 2, 2010
- Conatus Pharmaceuticals Acquires Pfizer's Idun Subsidiary - July 30, 2010
- Sunesis Issued European Patent Covering Voreloxin Combination - July 15, 2010
- Cadence Pharmaceuticals Signs Option Agreement to Acquire Incline Therapeutics - June 21, 2010
- BrainCells Announces Results From Exploratory Phase 2A Trial of BCI-540 - June 14, 2010
- IDev Technologies Announces European Launch of SUPERA VERITAS (TM) System - May 17, 2010
- BrainCells Gets First U.S. Patent For Drug Combinations To Modulate Neurogenesis - April 29, 2010
- Cadence Pharmaceuticals to Resubmit NDA for OFIRMEV(TM) - April 19, 2010
- MAP Pharmaceuticals Announces FREEDOM-301 P3 LEVADEX (TM) Trial Results - April 14, 2010
- Metabolex Initiates Research Collaboration with Takeda - April 13, 2010
- MAP Pharmaceuticals Initiates LEVADEX(TM) Pharmacodynamics Trial - April 7, 2010
- EnteroMedics Extends Neuroblocking Technology R&D Collaboration- March 17, 2010
- Sunesis to Proceed with P3 Trial of Voreloxin in Acute Myeloid Leukemia - February 25, 2010
- BioSeek Acquisition by Asterand Completed - February 18, 2010
- MAP Pharmaceuticals Initiates LEVADEX(TM) Pharmacokinetics Trial - February 16, 2010
- Cadence Pharmaceuticals Receives FDA Response for Acetaminophen IND - February 11, 2010
- Sunesis Grants Carmot Therapeutics License to its Drug Discovery Technology - February 8, 2010
- Poniard Pharmaceuticals Announces Management Changes and Staff Reductions - February 3, 2010
- Merus Closes EUR 21.7M Series B Financing - January 29, 2010
- EnteroMedics Announces Regulatory Process Forward After FDA Meeting - January 28, 2010
- EnteroMedics Announces EMPOWER and ENABLE Studies Data - January 14, 2010
- Sunesis Announces Publication of Voreloxin Data in Leukemias - January 14, 2010
- BioSeek Announces Acquisition by Asterand - November 18, 2009
- IDev Technologies Names Christopher M. Owens President, CEO - November 17, 2009
- Poniard Pharmaceuticals P3 SPEAR Trial Did Not Meet Primary Endpoint - November 16, 2009
- Cadence Pharmaceuticals Announces Extension of NDA Review - November 13, 2009
- EnteroMedics Announces Findings From Detailed Review of EMPOWER Study - November 12, 2009
- Metabolex Closes $8.6M Financing Round - November 5, 2009
- Epizyme Closes $32M Series B Financing, Led by Bay City Capital - October 7, 2009
- EnteroMedics Announces $4.9M Financing - October 2, 20009
- Calypso Medical Closes $50M Venture Financing Round - September 17, 2009
- PTC Therapeutics Initiates P3 Trial of Ataluren in Cystic Fibrosis - September 10, 2009
- PTC Therapeutics Announces Drug Discovery Collaboration with Roche - September 2, 2009
- PTC Therapeutics Announces Celgene Exercise of Option to Collaborate - September 2, 2009
- Poniard Pharmaceuticals Secures $60M Committed Equity Financing Facility - August 20, 2009
- NuPathe Reports Positive P3 Results for Zelrix - August 11, 2009
- PTC Therapeutics Achieves Milestone in Schering-Plough Collaboration - August 10, 2009
- BrainCells, Inc. Study Validates New Approach for Treating Mood Disorders - July 27, 2009
- Poniard Pharmaceuticals Announces Positive Cardiac Safety Data - July 21, 2009
- Cadence Pharmaceuticals NDA for Acetavance(TM) Accepted for Filing by FDA - July 15, 2009
- MAP Pharmaceuticals Announces Termination of Pediatric Asthma Collaboration - July 9, 2009
- Hyperion Therapeutics Announces Special Protocol Assessment from FDA - July 7, 2009
- Itamar Medical's WatchPAT (TM) Receives CPT (R) Code from the AMA - July 7, 2009
- Hyperion Therapeutics Raises $60M Series C - June 30, 2009
- EnteroMedics is Added to the Russell 3000 (R) Index - June 30, 2009
- Cadence Pharmaceuticals Appoints Scott Byrd as Chief Commercial Officer - June 22, 2009
- BioSeek and Merck Serono Extend 2008 Agreement - June 10, 2009
- EnteroMedics Announces Appointment of Nicholas Teti as Special Advisor - June 2, 2009
- Poniard Pharmaceuticals Announces Positive Data in Picoplatin P2 Trial - May 28, 2009
- MAP Pharmaceuticals P3 LEVADEX (TM) Trial Meets All Four Primary Endpoints - May 26, 2009
- Cadence Pharmaceuticals Submits NDA for Acetavance(TM) - May 14, 2009
- VIA Pharmaceuticals Completes Enrollment in FDG-PET Phase 2 Study - May 14, 2009
- PTC Therapeutics and Spinal Muscular Atrophy Foundation Expand Collaboration - May 12, 2009
- Ingenuity Systems Announces Multi-Year Deal with AstraZeneca - May 5, 2009
- Poniard Pharmaceuticals Announces DMC Support for Continuation of SPEAR Trial - May 5, 2009
- VIA Pharmaceuticals Announces Positive P2 Results of VIA-2291 Trial - May 1, 2009
- EnteroMedics Receives CE Mark Certification for VBLOC(TM) Therapy Device - March 9, 2009
- Cadence Pharmaceuticals Completes $86.6M Private Placement - February 19, 2009
- Poniard Pharmaceuticals Appoints New Chief Financial Officer - February 19, 2009
- Poniard Pharmaceuticals Announces Positive P2 Results in Picoplatin Trial - January 14, 2009
- EnteroMedics Announces Interim Results from VBLOC-RF2 Study - January 12, 2009
- Vivaldi Biosciences Enters into Agreements for $23M Series A Financing - January 8, 2009
- BioSeek and UCB Expand Collaboration Agreement - January 7. 2009
